¥2,091.00
2.83%
Tokyo, Nov 06, 03:15 pm JST. Closed.
ISIN
JP3823600006
Symbol
4538

Fuso Pharmaceutical Industries,ltd. Stock price

¥2,091.00
-63.00 2.92% 1M
-140.00 6.28% 6M
-224.00 9.68% YTD
-30.00 1.41% 1Y
+162.00 8.40% 3Y
-466.00 18.22% 5Y
-580.00 21.71% 10Y
-1,239.00 37.21% 20Y
Tokyo, Closing price Fri, Nov 06 2026
-61.00 2.83%
ISIN
JP3823600006
Symbol
4538
Industry

AI Insights on Fuso Pharmaceutical Industries,ltd. Insights AI Insights on Fuso Pharmaceutical Industries,ltd.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Fuso Pharmaceutical Industries,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
¥18.4b
Enterprise Value
¥40.1b
Net debt
¥21.7b
Cash
¥4.6b
Shares outstanding
8.5m
Valuation
P/E
8.1
P/S | estimate
0.3 | -
EV/Sales | estimate
0.6 | -
EV/FCF | ex SBC
negative | -
P/B
0.5
Dividends
DPS
¥90.00
Yield 1Y | 5Y
4.3% | 3.7%
Growth 1Y | 5Y
0.0% | 8.5%
Payout 1Y | 3Y
38.2% | 2,296.0%
Increased
0 Years
Financials
Revenue | estimate
¥62.9b | -
EBITDA
-
EBIT
¥3.0b
Net Income
¥2.2b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
2.3% | -
EBITDA
-
EBIT
158.3%
Net Income
163.4%
Free Cash Flow
-
Margin
Gross
25.6%
EBITDA
-
EBIT
4.8%
Net
3.5%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
38.8%
Return on Equity
5.7%
ROCE
7.7%
ROIC
4.1%
Debt/Equity
0.7
More
EPS
¥256.7
FCF per Share
-
Short interest
-
Employees
1k
Rev per Employee
¥45.5m

Fuso Pharmaceutical Industries,ltd. Events

Upcoming Event
NOV
11
Q2 2027 Earnings Call
in 3 days

Financial data from Fuso Pharmaceutical Industries,ltd.

Jun '26
+/-
%
62,850 62,850
2% 2%
100%
- Direct Costs 46,736 46,736
4% 4%
74%
16,114 16,114
2% 2%
26%
- Selling and Administrative Expenses 13,098 13,098
2% 2%
21%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 3,013 3,013
158% 158%
5%
Net Profit 2,191 2,191
163% 163%
3%

In millions JPY.

Don't miss a Thing! We will send you all news about Fuso Pharmaceutical Industries,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. The company is headquartered in Osaka, Osaka-Fu and currently employs 1,340 full-time employees. The pharmaceuticals business involves the manufacture and sale of pharmaceuticals and medical equipment, including injectables centered on infusion solutions and dialysis agents for artificial kidneys, as well as contract manufacturing of pharmaceuticals. The real estate business involves the leasing of real estate.

Head office Japan
Employees 1,370
Website www.fuso-pharm.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today